Circulating BAFF levels have been found elevated in many patients with autoimmune diseases and, as a vital B-cell survival factor, it has emerged as a logical therapeutic target for combating B-cell hyperactivity. The gene discussed is TNFSF13B; the disease is autoimmune disease.